Wordt geladen...
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
Despite considerable advances in the treatment of multiple myeloma (MM) in the last decade, a substantial proportion of patients do not respond to current therapies or have a short duration of response. Furthermore, these treatments can have notable morbidity and are not uniformly tolerated in all p...
Bewaard in:
| Gepubliceerd in: | Leukemia |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214244/ https://ncbi.nlm.nih.gov/pubmed/32055000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-020-0734-z |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|